Patent details
EP4025253
Title:
DRUG ANTIBODY CONJUGATES
Basic Information
- Publication number:
- EP4025253
- PCT Application Number:
- EP2020074695
- Type:
- European Patent Granted for LU
- Legal Status:
- Lapsed
- Application number:
- EP207644063
- PCT Publication Number:
- WO2021043951
- First applicant's nationality:
- Translation Language:
- EPO Publication Language:
- English
- English Title of Invention:
- DRUG ANTIBODY CONJUGATES
- French Title of Invention:
- CONJUGUÉS ANTICORPS-MÉDICAMENTS
- German Title of Invention:
- ARZNEIMITTEL-ANTIKÖRPER-KONJUGATE
- SPC Number:
-
Dates
- Filing date:
- 04/09/2020
- Grant date:
- 20/03/2024
- EP Publication Date:
- 13/07/2022
- PCT Publication Date:
- 11/03/2021
- Claims Translation Received Date:
- Translations Received Date (B1 EP Publication):
- Translations Received Date (B2 EP Publication):
- Translations Received Date (B3 EP Publication):
- Publication date:
- 20/03/2024
- EP B1 Publication Date:
- 20/03/2024
- EP B2 Publication Date:
- EP B3 Publication Date:
- Lapsed date:
- 04/09/2024
- Expiration date:
- 04/09/2040
- Renunciation date:
- Revocation date:
- Annulment date:
Owner
- From:
- 13/03/2024
-
-
- Name:
- Pharma Mar, S.A.
- Address:
- Polígono Industrial La Mina
Avda. de los Reyes, 1
Colmenar Viejo, 28770 Madrid, Spain (ES)
Inventor
1
- Name:
- GUTIÉRREZ LORIENTE, Agustín
- Address:
- Spain (ES)
2
- Name:
- LATORRE LOZANO, Alfonso
- Address:
- Spain (ES)
3
- Name:
- CUEVAS MARCHANTE, Maria Del Carmen
- Address:
- Spain (ES)
Priority
- Priority Number:
- 19382765
- Priority Date:
- 05/09/2019
- Priority Country:
- European Patent Office (EPO) (EP)
Classification
- IPC classification:
-
A61K 47/68;
A61K 31/351;
C07D 309/10;
Publication
European Patent Bulletin
- Issue number:
- 202412
- Publication date:
- 20/03/2024
- Description:
- Grant (B1)
Annual Fees
- Annual Fee Due Date:
-
- Annual Fee Number:
-
- Expected Payer:
-
- Last Annual Fee Payment Date:
-
- Last Annual Fee Paid Number:
-
- Payer:
-
Filing date |
Document type |
Number of pages |